Raloxifene 6-glucuronide

574221

Raloxifene 6-glucuronide

907.5 €

HY-135581

Raloxifene 6-glucuronide

Raloxifene 6-glucuronide is a primary metabolite of Raloxifene. Raloxifene 6-glucuronide is mediated mostly by UGT1A1 and UGT1A8. Raloxifene 6-glucuronide binds to estrogen receptor with an IC50 of 290 μM. Raloxifene is a selective and nonsteroidal estrogen receptor modulator. Raloxifene activates TGFβ3 promoter as a full agonist at nanomolar concentrations, and inhibits the estrogen response element-containing vitellogenin promoter expression[1][2][3].

1274.11 €

T12688-10mg

Raloxifene 6-glucuronide

Raloxifene 6-glucuronide

Ask for quotation

MBS6060508-05mg

Raloxifene 6,4'-Bis-beta-D-glucuronide

1013.75 €

MBS6060508-5x05mg

Raloxifene 6,4'-Bis-beta-D-glucuronide

3710.38 €

HY-135595

6-Raloxifene-β-D-glucopyranoside

6-Raloxifene-β-D-glucopyranoside, a derivative of Raloxifene, is a benzothiophene glucuronidated at the 6' postion. 6-Raloxifene-β-D-glucopyranoside is a selective and orally active estrogen receptor antagonist. 6-Raloxifene-β-D-glucopyranoside can be used for inhibiting bone loss and resorption, and lowering lipid levels. 6'-Raloxifene-β-D-glucopyranoside, compound Ia, is extracted from patent US5567820A[1].

Ask for quotation